Telbivudine versus Entecavir in Patients with Chronic Hepatitis B: 2-Year Results of a Head-To-Head Trial

被引：0
|
作者：
Huang, Jing [1 ]
Chen, Xiaoping [1 ]
Chen, Xuefu [1 ]
Chen, Re [1 ]
Chen, Wenli [1 ]
Ma, Xiaojun [1 ]
Luo, Xiaodan [1 ]
机构：
[1] Guangdong Acad Med Sci, Guangdong Gen Hosp, Guangzhou, Guangdong, Peoples R China
来源：
HEPATOLOGY | 2013年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
983
引用
收藏
页码：681A / 681A
页数：1
相关论文
共 50 条
  • [1] HEAD-TO-HEAD COMPARISON OF VIRAL KINETICS OF TELBIVUDINE AND ENTECAVIR IN PATIENTS WITH CHRONIC HEPATITIS B OVER THE FIRST 12 WEEKS OF TREATMENT
    Suh, Dong J.
    Herrmann, Eva
    Zeuzem, Stefan
    Um, Soon ho
    Lee, Han Chu
    Kim, Ju Hyun
    Lee, Young-Sok
    Lopez, Patricia M.
    Avila, Claudio
    HEPATOLOGY, 2008, 48 (04) : 719A - 720A
  • [2] 2-Year GLOBE Trial Results: Telbivudine Is Superior to Lamivudine in Patients With Chronic Hepatitis B
    Liaw, Yun-Fan
    Gane, Edward
    Leung, Nancy
    Zeuzem, Stefan
    Wang, Yuming
    Lai, Ching Lung
    Heathcote, E. Jenny
    Manns, Michael
    Bzowej, Natalie
    Niu, Junqi
    Han, Steven-Huy
    Hwang, Seong Gyu
    Cakaloglu, Yilmaz
    Tong, Myron J.
    Papatheodoridis, George
    Chen, Yagang
    Brown, Nathaniel A.
    Albanis, Efsevia
    Galil, Karin
    Naoumov, Nikolai V.
    GASTROENTEROLOGY, 2009, 136 (02) : 486 - 495
  • [3] A comparison of efficacy and safety of 2-year telbivudine and entecavir treatment in patients with chronic hepatitis B: a match-control study
    Tsai, M-C.
    Chen, C-H.
    Hung, C-H.
    Lee, C-M.
    Chiu, K-W.
    Wang, J-H.
    Lu, S-N.
    Tseng, P-L.
    Chang, K-C.
    Yen, Y-H.
    Hu, T-H.
    CLINICAL MICROBIOLOGY AND INFECTION, 2014, 20 (02) : O90 - O100
  • [4] Telbivudine versus entecavir in patients with undetectable hepatitis B virus DNA: a randomized trial
    An, Jihyun
    Lim, Young-Suk
    Kim, Gi-Ae
    Han, Seong-bong
    Jeong, Wonhee
    Lee, Danbi
    Shim, Ju Hyun
    Lee, Han Chu
    Lee, Yung Sang
    BMC GASTROENTEROLOGY, 2017, 17
  • [5] Telbivudine versus entecavir in patients with undetectable hepatitis B virus DNA: a randomized trial
    Jihyun An
    Young-Suk Lim
    Gi-Ae Kim
    Seong-bong Han
    Wonhee Jeong
    Danbi Lee
    Ju Hyun Shim
    Han Chu Lee
    Yung Sang Lee
    BMC Gastroenterology, 17
  • [6] FIVE-YEAR OUTCOME OF TELBIVUDINE VERSUS ENTECAVIR IN TREATING HIGH VIRAL LOAD CHRONIC HEPATITIS B PATIENTS
    Pan, H. -Y.
    Ren, Z. -Z.
    Huang, H. -J.
    Zou, H.
    Tong, Y. -X.
    Yang, D. -H.
    Pan, H. -Y.
    Chen, M. -J.
    Wang, M. -S.
    Huang, Y. -C.
    Zhang, J. -J.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S590 - S591
  • [7] Telbivudine versus lamivudine in Chinese patients with chronic hepatitis B: Results at 1 year of a randomized, double-blind trial
    Hou, Jinlin
    Yin, You-Kuan
    Xu, Daozhen
    Tan, Deming
    Niu, Junqi
    Zhou, Xiaqiu
    Wang, Yuming
    Zhu, Limin
    He, Yongwen
    Ren, Hong
    Wan, Mobin
    Chen, Chengwei
    Wu, Shanming
    Chen, Yagang
    Xu, Jiazhang
    Wang, Qinhuan
    Wei, Lai
    Chao, George
    Constance, Barbara Fielman
    Harb, George
    Brown, Nathaniel A.
    Jia, Jidong
    HEPATOLOGY, 2008, 47 (02) : 447 - 454
  • [8] First Results of a Head-to-Head Trial of Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia
    Byrd, John C.
    Hillmen, Peter
    Ghia, Paolo
    Kater, Arnon P.
    Chanan-Khan, Asher
    Furman, Richard R.
    O'Brien, Susan
    Yenerel, Mustafa Nuri
    Illes, Arpad
    Kay, Neil
    Garcia-Marco, Jose A.
    Mato, Anthony
    Pinilla-Ibarz, Javier
    Seymour, John F.
    Lepretre, Stephane
    Stilgenbauer, Stephan
    Robak, Tadeusz
    Patel, Priti
    Higgins, Kara
    Sohoni, Sophia
    Jurczak, Wojciech
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S318 - S318
  • [9] First results of a head-to-head trial of acalabrutinib versus ibrutinib in previously treated chronic lymphocytic leukemia
    Stilgenbauer, S.
    Byrd, J. C.
    Hillmen, P.
    Ghia, P.
    Kater, A. P.
    Chanan-Khan, A.
    Furman, R. R.
    O'Brien, S.
    Yenerel, M. N.
    Illes, A.
    Kay, N.
    Garcia-Marco, J. A.
    Mato, A.
    Seymour, J. F.
    Lepretre, S.
    Robak, T.
    Patel, P.
    Higgins, K.
    Sohoni, S.
    Jurczak, W.
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 105 - 105
  • [10] A comparison of treatment with adefovir and entecavir for chronic hepatitis B in China: The 2-year results of a prospective study
    Chen, En Qiang
    Zhou, Tao You
    Liu, Li
    Liu, Cong
    Lei, Ming
    Tang, Hong
    HEPATITIS MONTHLY, 2011, 11 (01) : 27 - 32
12345